Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?

Todd M. Brown, Dhananjay Vaidya, William J. Rogers, David D. Waters, Barbara V. Howard, Jean Claude Tardif, Vera Bittner

Research output: Contribution to journalArticle

Abstract

Background: The definition and prognostic utility of the metabolic syndrome remain controversial. Analyses in predominantly healthy populations suggest that the International Diabetes Federation (IDF) definition identifies more men with metabolic syndrome than the Adult Treatment Panel III (ATP III) criteria, with little difference among women. Whether the IDF definition identifies a greater prevalence of the metabolic syndrome than the ATP III definition in women with coronary artery disease (CAD) is unknown. Methods: We compared the prevalence and prognostic utility of both definitions of the metabolic syndrome in postmenopausal women with angiographic CAD enrolled in the Women's Angiographic Vitamin and Estrogen Trial (WAVE). We excluded 51 of 423 women enrolled (12%) who had missing data for components of the metabolic syndrome. Results: Mean age was 65.3 ± 8.4 years, 70% were white, mean body mass index (BMI) was 30.5 ± 6.0 kg/m2, mean waist circumference was 96.2 ± 12.9 cm, 89% had hypertension by history or elevated blood pressure, 58% had diabetes or hyperglycemia, 54% had low high-density lipoprotein cholesterol (HDL-C), and 44% had hypertriglyceridemia. Metabolic syndrome prevalence was 70% and 74% by ATP III and IDF criteria, respectively; 68% met criteria for both definitions. Classification between the two criteria was not affected by ethnicity or age. Incident cardiovascular events were similar in both metabolic syndrome classifications. Conclusions: Among postmenopausal women with angiographic CAD, the metabolic syndrome is very prevalent. The IDF modification of the ATP III definition only identifies a small additional number of women as having metabolic syndrome, independent of ethnicity or age, and provides little additional prognostic information.

Original languageEnglish (US)
Pages (from-to)841-847
Number of pages7
JournalJournal of Women's Health
Volume17
Issue number5
DOIs
StatePublished - Jun 1 2008

Fingerprint

Coronary Artery Disease
Therapeutics
Hypertriglyceridemia
Waist Circumference
Vitamins
Hyperglycemia
LDL Cholesterol
HDL Cholesterol
Estrogens
Body Mass Index
History
Blood Pressure
Hypertension
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? / Brown, Todd M.; Vaidya, Dhananjay; Rogers, William J.; Waters, David D.; Howard, Barbara V.; Tardif, Jean Claude; Bittner, Vera.

In: Journal of Women's Health, Vol. 17, No. 5, 01.06.2008, p. 841-847.

Research output: Contribution to journalArticle

Brown, Todd M. ; Vaidya, Dhananjay ; Rogers, William J. ; Waters, David D. ; Howard, Barbara V. ; Tardif, Jean Claude ; Bittner, Vera. / Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?. In: Journal of Women's Health. 2008 ; Vol. 17, No. 5. pp. 841-847.
@article{a1473b31799741ffb258db7911e779a4,
title = "Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?",
abstract = "Background: The definition and prognostic utility of the metabolic syndrome remain controversial. Analyses in predominantly healthy populations suggest that the International Diabetes Federation (IDF) definition identifies more men with metabolic syndrome than the Adult Treatment Panel III (ATP III) criteria, with little difference among women. Whether the IDF definition identifies a greater prevalence of the metabolic syndrome than the ATP III definition in women with coronary artery disease (CAD) is unknown. Methods: We compared the prevalence and prognostic utility of both definitions of the metabolic syndrome in postmenopausal women with angiographic CAD enrolled in the Women's Angiographic Vitamin and Estrogen Trial (WAVE). We excluded 51 of 423 women enrolled (12{\%}) who had missing data for components of the metabolic syndrome. Results: Mean age was 65.3 ± 8.4 years, 70{\%} were white, mean body mass index (BMI) was 30.5 ± 6.0 kg/m2, mean waist circumference was 96.2 ± 12.9 cm, 89{\%} had hypertension by history or elevated blood pressure, 58{\%} had diabetes or hyperglycemia, 54{\%} had low high-density lipoprotein cholesterol (HDL-C), and 44{\%} had hypertriglyceridemia. Metabolic syndrome prevalence was 70{\%} and 74{\%} by ATP III and IDF criteria, respectively; 68{\%} met criteria for both definitions. Classification between the two criteria was not affected by ethnicity or age. Incident cardiovascular events were similar in both metabolic syndrome classifications. Conclusions: Among postmenopausal women with angiographic CAD, the metabolic syndrome is very prevalent. The IDF modification of the ATP III definition only identifies a small additional number of women as having metabolic syndrome, independent of ethnicity or age, and provides little additional prognostic information.",
author = "Brown, {Todd M.} and Dhananjay Vaidya and Rogers, {William J.} and Waters, {David D.} and Howard, {Barbara V.} and Tardif, {Jean Claude} and Vera Bittner",
year = "2008",
month = "6",
day = "1",
doi = "10.1089/jwh.2007.0536",
language = "English (US)",
volume = "17",
pages = "841--847",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?

AU - Brown, Todd M.

AU - Vaidya, Dhananjay

AU - Rogers, William J.

AU - Waters, David D.

AU - Howard, Barbara V.

AU - Tardif, Jean Claude

AU - Bittner, Vera

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Background: The definition and prognostic utility of the metabolic syndrome remain controversial. Analyses in predominantly healthy populations suggest that the International Diabetes Federation (IDF) definition identifies more men with metabolic syndrome than the Adult Treatment Panel III (ATP III) criteria, with little difference among women. Whether the IDF definition identifies a greater prevalence of the metabolic syndrome than the ATP III definition in women with coronary artery disease (CAD) is unknown. Methods: We compared the prevalence and prognostic utility of both definitions of the metabolic syndrome in postmenopausal women with angiographic CAD enrolled in the Women's Angiographic Vitamin and Estrogen Trial (WAVE). We excluded 51 of 423 women enrolled (12%) who had missing data for components of the metabolic syndrome. Results: Mean age was 65.3 ± 8.4 years, 70% were white, mean body mass index (BMI) was 30.5 ± 6.0 kg/m2, mean waist circumference was 96.2 ± 12.9 cm, 89% had hypertension by history or elevated blood pressure, 58% had diabetes or hyperglycemia, 54% had low high-density lipoprotein cholesterol (HDL-C), and 44% had hypertriglyceridemia. Metabolic syndrome prevalence was 70% and 74% by ATP III and IDF criteria, respectively; 68% met criteria for both definitions. Classification between the two criteria was not affected by ethnicity or age. Incident cardiovascular events were similar in both metabolic syndrome classifications. Conclusions: Among postmenopausal women with angiographic CAD, the metabolic syndrome is very prevalent. The IDF modification of the ATP III definition only identifies a small additional number of women as having metabolic syndrome, independent of ethnicity or age, and provides little additional prognostic information.

AB - Background: The definition and prognostic utility of the metabolic syndrome remain controversial. Analyses in predominantly healthy populations suggest that the International Diabetes Federation (IDF) definition identifies more men with metabolic syndrome than the Adult Treatment Panel III (ATP III) criteria, with little difference among women. Whether the IDF definition identifies a greater prevalence of the metabolic syndrome than the ATP III definition in women with coronary artery disease (CAD) is unknown. Methods: We compared the prevalence and prognostic utility of both definitions of the metabolic syndrome in postmenopausal women with angiographic CAD enrolled in the Women's Angiographic Vitamin and Estrogen Trial (WAVE). We excluded 51 of 423 women enrolled (12%) who had missing data for components of the metabolic syndrome. Results: Mean age was 65.3 ± 8.4 years, 70% were white, mean body mass index (BMI) was 30.5 ± 6.0 kg/m2, mean waist circumference was 96.2 ± 12.9 cm, 89% had hypertension by history or elevated blood pressure, 58% had diabetes or hyperglycemia, 54% had low high-density lipoprotein cholesterol (HDL-C), and 44% had hypertriglyceridemia. Metabolic syndrome prevalence was 70% and 74% by ATP III and IDF criteria, respectively; 68% met criteria for both definitions. Classification between the two criteria was not affected by ethnicity or age. Incident cardiovascular events were similar in both metabolic syndrome classifications. Conclusions: Among postmenopausal women with angiographic CAD, the metabolic syndrome is very prevalent. The IDF modification of the ATP III definition only identifies a small additional number of women as having metabolic syndrome, independent of ethnicity or age, and provides little additional prognostic information.

UR - http://www.scopus.com/inward/record.url?scp=45149094319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45149094319&partnerID=8YFLogxK

U2 - 10.1089/jwh.2007.0536

DO - 10.1089/jwh.2007.0536

M3 - Article

C2 - 18537485

AN - SCOPUS:45149094319

VL - 17

SP - 841

EP - 847

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 5

ER -